Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States

Volume: 14, Issue: 2, Pages: 121 - 129
Published: Feb 1, 2018
Abstract
null Introduction null We forecast the prevalence of preclinical and clinical Alzheimer's disease (AD) and evaluated potential impacts of primary and secondary preventions in the United States. null Methods null We used a multistate model incorporating biomarkers for preclinical AD with US population projections. null Results null Approximately 6.08 million Americans had either clinical AD or mild cognitive impairment due to AD in 2017 and that...
Paper Details
Title
Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
Published Date
Feb 1, 2018
Volume
14
Issue
2
Pages
121 - 129
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.